Delineating transcriptional networks of prognostic gene signatures refines treatment recommendations for lymph node-negative breast cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Delineating transcriptional networks of prognostic gene signatures refines treatment recommendations for lymph node-negative breast cancer patients

Published:2015-07-14 Issue:18 Volume:282 Page:3455-3473
ISSN:1742-464X
Container-title:FEBS Journal
language:en
Short-container-title:FEBS J

Author:

Lanigan Fiona¹,Brien Gerard L.¹,Fan Yue²,Madden Stephen F.²,Jerman Emilia¹,Maratha Ashwini²,Aloraifi Fatima¹,Hokamp Karsten¹,Dunne Eiseart J.¹,Lohan Amanda J.²,Flanagan Louise³,Garbe James C.⁴,Stampfer Martha R.⁴,Fridberg Marie⁵,Jirstrom Karin⁵,Quinn Cecily M.³,Loftus Brendan²,Gallagher William M.²,Geraghty James³,Bracken Adrian P.¹

Affiliation:

1. The Smurfit Institute of Genetics; Trinity College Dublin; Ireland

2. UCD School of Biomolecular and Biomedical Science; UCD Conway Institute; University College Dublin; Ireland

3. Department of Histopathology; St Vincent's University Hospital; Dublin Ireland

4. Life Science Division; Lawrence Berkeley National Laboratory; Berkeley CA USA

5. Department of Clinical Sciences, Division of Oncology and Pathology; Lund University; Sweden

Funder

Science Foundation Ireland

Health Research Board

Enterprise Ireland

The Irish Research Council

St Vincent's Foundation

US Department of Energy

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/febs.13354/fullpdf

Reference63 articles.

1. Effect of three decades of screening mammography on breast-cancer incidence;Bleyer;N Engl J Med,2012

2. Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials;Fisher;Lancet,2004

3. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009;Goldhirsch;Ann Oncol,2009

4. Can some patients avoid adjuvant chemotherapy for early-stage breast cancer?;Bedard;Nat Rev Clin Oncol,2011

5. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival;Chang;Proc Natl Acad Sci USA,2005

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Downregulation of IGFBP5 contributes to replicative senescence via ERK2 activation in mouse embryonic fibroblasts;Aging;2022-04-04

2. Analytical Validation of a Novel 6-Gene Signature for Prediction of Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative, Early-Stage Breast Cancer;Clinical Chemistry;2022-03-21

3. The OncoMasTR Test Predicts Distant Recurrence in Estrogen Receptor–Positive, HER2-Negative Early-Stage Breast Cancer: A Validation Study in ABCSG Trial 8;Clinical Cancer Research;2021-08-11

4. Prognostic value of the 6-gene OncoMasTR test in hormone receptor–positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factors;European Journal of Cancer;2021-07

5. Future of biomarker evaluation in the realm of artificial intelligence algorithms: application in improved therapeutic stratification of patients with breast and prostate cancer;Journal of Clinical Pathology;2021-06-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3